184 related articles for article (PubMed ID: 10084598)
1. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B
J Clin Endocrinol Metab; 1999 Mar; 84(3):1077-82. PubMed ID: 10084598
[TBL] [Abstract][Full Text] [Related]
2. The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B; Connelly PW
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):217-22. PubMed ID: 10634821
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
J Clin Endocrinol Metab; 2000 May; 85(5):2014-9. PubMed ID: 10843190
[TBL] [Abstract][Full Text] [Related]
4. Genes, environment and Oji-Cree type 2 diabetes.
Hegele RA; Zinman B; Hanley AJ; Harris SB; Barrett PH; Cao H
Clin Biochem; 2003 May; 36(3):163-70. PubMed ID: 12726923
[TBL] [Abstract][Full Text] [Related]
5. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community.
Triggs-Raine BL; Kirkpatrick RD; Kelly SL; Norquay LD; Cattini PA; Yamagata K; Hanley AJ; Zinman B; Harris SB; Barrett PH; Hegele RA
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4614-9. PubMed ID: 11904371
[TBL] [Abstract][Full Text] [Related]
6. Gender, obesity, hepatic nuclear factor-1alpha G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
Int J Obes Relat Metab Disord; 2000 Aug; 24(8):1062-4. PubMed ID: 10951547
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of the HNF-1alpha G319S mutation in Canadian aboriginal youth with type 2 diabetes.
Sellers EA; Triggs-Raine B; Rockman-Greenberg C; Dean HJ
Diabetes Care; 2002 Dec; 25(12):2202-6. PubMed ID: 12453961
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians.
Hegele RA; Cao H; Hanley AJ; Zinman B; Harris SB; Anderson CM
Diabetes Care; 2000 Jun; 23(6):775-8. PubMed ID: 10840995
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factor-1 alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes.
Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B
Diabetes Care; 1999 Mar; 22(3):524. PubMed ID: 10097940
[No Abstract] [Full Text] [Related]
10. Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Hanley AJ; Zinman B; Harris SB; Anderson CM
J Hum Genet; 2000; 45(3):184-7. PubMed ID: 10807546
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians.
Baier LJ; Permana PA; Traurig M; Dobberfuhl A; Wiedrich C; Sutherland J; Thuillez P; Luczy-Bachman G; Hara M; Horikawa Y; Hinokio Y; Hanson RL; Bogardus C
Diabetes Care; 2000 Mar; 23(3):302-4. PubMed ID: 10868855
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional analysis of mutations in the hepatocyte nuclear factor-1alpha gene in anti-islet autoantibody-negative Japanese patients with type 1 diabetes.
Kawasaki E; Sera Y; Yamakawa K; Abe T; Ozaki M; Uotani S; Ohtsu N; Takino H; Yamasaki H; Yamaguchi Y; Matsuura N; Eguchi K
J Clin Endocrinol Metab; 2000 Jan; 85(1):331-5. PubMed ID: 10634407
[TBL] [Abstract][Full Text] [Related]
13. Identification of a new mutation in the hepatocyte nuclear factor-1alpha gene in a Polish family with early-onset type 2 diabetes mellitus.
Malecki MT; Klupa T; Frey J; Cyganek K; Galicka-Stankowska D; Wanic K; Sieradzki J
Diabetes Nutr Metab; 2001 Oct; 14(5):288-91. PubMed ID: 11806470
[TBL] [Abstract][Full Text] [Related]
14. Identification of seven novel nucleotide variants in the hepatocyte nuclear factor-1alpha (TCF1) promoter region in MODY patients.
Godart F; Bellanné-Chantelot C; Clauin S; Gragnoli C; Abderrahmani A; Blanché H; Boutin P; Chèvre JC; Froguel P; Bailleul B
Hum Mutat; 2000; 15(2):173-80. PubMed ID: 10649494
[TBL] [Abstract][Full Text] [Related]
15. Human insulin gene is a target gene of hepatocyte nuclear factor-1alpha (HNF-1alpha) and HNF-1beta.
Okita K; Yang Q; Yamagata K; Hangenfeldt KA; Miyagawa J; Kajimoto Y; Nakajima H; Namba M; Wollheim CB; Hanafusa T; Matsuzawa Y
Biochem Biophys Res Commun; 1999 Sep; 263(2):566-9. PubMed ID: 10491332
[TBL] [Abstract][Full Text] [Related]
16. Genes and environment in type 2 diabetes and atherosclerosis in aboriginal Canadians.
Hegele RA
Curr Atheroscler Rep; 2001 May; 3(3):216-21. PubMed ID: 11286643
[TBL] [Abstract][Full Text] [Related]
17. Structure/function studies of hepatocyte nuclear factor-1alpha, a diabetes-associated transcription factor.
Yang Q; Yamagata K; Yamamoto K; Miyagawa J; Takeda J; Iwasaki N; Iwahashi H; Yoshiuchi I; Namba M; Miyazaki J; Hanafusa T; Matsuzawa Y
Biochem Biophys Res Commun; 1999 Dec; 266(1):196-202. PubMed ID: 10581189
[TBL] [Abstract][Full Text] [Related]
18. MODY associated with two novel hepatocyte nuclear factor-1alpha loss-of-function mutations (P112L and Q466X).
Bjørkhaug L; Ye H; Horikawa Y; Søvik O; Molven A; Njølstad PR
Biochem Biophys Res Commun; 2000 Dec; 279(3):792-8. PubMed ID: 11162430
[TBL] [Abstract][Full Text] [Related]
19. The Ala/Val98 polymorphism of the hepatocyte nuclear factor-1alpha gene contributes to the interindividual variation in serum C-peptide response during an oral glucose tolerance test: evidence from studies of 231 glucose-tolerant first degree relatives of type 2 diabetic probands.
Urhammer SA; Hansen T; Ekstrøm CT; Eiberg H; Pedersen O
J Clin Endocrinol Metab; 1998 Dec; 83(12):4506-9. PubMed ID: 9851800
[TBL] [Abstract][Full Text] [Related]
20. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
